Revolution Health and EmergingMed Launch Cancer Clinical Trial Matching and Referral Service
A partnership between Revolution Health and EmergingMed expands online services and helps match patients with the right clinical trials.
Washington, DC, and New York, NY-May 14, 2008-Revolution Health (www.revolutionhealth.com) and EmergingMed (www.emergingmed.com) today announced that they have teamed up to offer patients and physicians the largest personalized cancer clinical trial matching and referral service in the United States. Individuals can quickly assess their eligibility for more than 10,000 clinical trial listings in a confidential and efficient way through an online search engine or by calling a clinical trial specialist. The service, powered by EmergingMed, is offered for free on www.revolutionhealth.com.
"Through our online communities, RevolutionHealth.com is helping change people's lives, giving them the information, tools, and support they need to live healthier and to find key resources to help navigate the health care system when they are sick," said Brad Jacobs MD, senior medical director of Revolution Health. "EmergingMed's online matching service and health call center provide key linkage points for patients and their caregivers when looking for clinical trials."
"EmergingMed is committed to providing personalized services to patients who are exploring treatment options," remarked Courtney Hudson, EmergingMed's founder and chief executive officer. "We believe patients should have access to the latest research options targeting their specific diagnoses. Our partnership with Revolution Health helps us reach a new, broad group of patients and families."
Revolution Health's new cancer clinical trial matching service offers both Internet-based and telephone-based service. With permission, the call center's Clinical Trial Specialists place follow-up calls to patients to ensure successful connection with a clinical trial site, address basic clinical trial questions, and provide logistical support through the search process.
To access the online search engine, visit www.revolutionhealth.com, select a cancer type, and click "Clinical Trials" in the left column. To search by phone, call toll-free (866) 890-6608.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
